The epidemiology of glioma in adults: a "state of the science" review.
暂无分享,去创建一个
J. Barnholtz-Sloan | Q. Ostrom | F. Davis | M. Wrensch | J. Schwartzbaum | M. Turner | K. Walsh | M. Pekmezci | L. Bauchet | I. Deltour | J. Fisher | C. E. Langer
[1] P. Bracci,et al. Interaction of allergy history and antibodies to specific varicella‐zoster virus proteins on glioma risk , 2014, International journal of cancer.
[2] Joachim Schüz,et al. Authors' response to: the case of acoustic neuroma: comment on mobile phone use and risk of brain neoplasms and other cancers. , 2014, International journal of epidemiology.
[3] Daniel Krewski,et al. Occupational Exposure to Extremely Low-Frequency Magnetic Fields and Brain Tumor Risks in the INTEROCC Study , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[4] J. Barnholtz-Sloan,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.
[5] M. Bondy,et al. Antihistamine use and immunoglobulin E levels in glioma risk and prognosis. , 2013, Cancer epidemiology.
[6] D. Haussler,et al. The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.
[7] K. H. Mild,et al. Case-control study of the association between malignant brain tumours diagnosed between 2007 and 2009 and mobile and cordless phone use , 2013, International journal of oncology.
[8] Susan M. Chang,et al. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis. , 2013, Neuro-oncology.
[9] T. Holland-Letz,et al. ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis , 2013, Acta Neuropathologica.
[10] K. Ichimura,et al. Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss , 2013, Acta Neuropathologica.
[11] Guan Sun,et al. Association between polymorphisms in interleukin-4Rα and interleukin-13 and glioma risk: a meta-analysis. , 2013, Cancer epidemiology.
[12] V. Beral,et al. Mobile phone use and risk of brain neoplasms and other cancers: prospective study. , 2013, International journal of epidemiology.
[13] J. Mathews,et al. Cancer risk in 680 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians , 2013, BMJ.
[14] Juan F. García,et al. Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors , 2013, Acta Neuropathologica.
[15] Yiheng Zhou,et al. MGMT promoter methylation and glioblastoma prognosis: a systematic review and meta-analysis. , 2013, Archives of medical research.
[16] Alexander R. Pico,et al. Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology. , 2013, Neuro-oncology.
[17] K. Hoang-Xuan,et al. Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies. , 2013, Neuro-oncology.
[18] K. Strauch,et al. Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222 , 2013, British Journal of Cancer.
[19] J. Michael Gaziano,et al. Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma , 2013, Journal of Neuro-Oncology.
[20] Gary L. Gallia,et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal , 2013, Proceedings of the National Academy of Sciences.
[21] G. Giles,et al. Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, Canada, France, Israel, and New Zealand , 2013, Cancer Causes & Control.
[22] K. Strauch,et al. Deciphering the 8q24.21 association for glioma. , 2013, Human molecular genetics.
[23] Alexander R. Pico,et al. Analysis of 60 Reported Glioma Risk SNPs Replicates Published GWAS Findings but Fails to Replicate Associations From Published Candidate‐Gene Studies , 2013, Genetic epidemiology.
[24] S. Rohrmann,et al. Primary brain tumour epidemiology in Georgia: first-year results of a population-based study , 2013, Journal of Neuro-Oncology.
[25] R. Goldbohm,et al. Occupational extremely low-frequency magnetic field exposure and selected cancer outcomes in a prospective Dutch cohort , 2013, Cancer Causes & Control.
[26] J. Barnholtz-Sloan,et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. , 2013, Neuro-oncology.
[27] R. Jenkins,et al. Genetics of adult glioma. , 2012, Cancer genetics.
[28] Hideo Nakamura,et al. Importance of direct macrophage ‐ Tumor cell interaction on progression of human glioma , 2012, Cancer science.
[29] M. Barchana,et al. Changes in brain glioma incidence and laterality correlates with use of mobile phones--a nationwide population based study in Israel. , 2012, Asian Pacific journal of cancer prevention : APJCP.
[30] J. Buckner,et al. Conditional probability of long‐term survival in glioblastoma , 2012, Cancer.
[31] Geirmund Unsgård,et al. Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. , 2012, JAMA.
[32] P. Stewart,et al. The Upper Midwest Health Study: gliomas and occupational exposure to chlorinated solvents , 2012, Occupational and Environmental Medicine.
[33] Alexander R. Pico,et al. A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation , 2012, Nature Genetics.
[34] Timothy A. Chan,et al. Whole exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma , 2012, Oncotarget.
[35] R. Elston,et al. A Variable Age of Onset Segregation Model for Linkage Analysis, with Correction for Ascertainment, Applied to Glioma , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[36] Kathleen M Waters,et al. The Upper Midwest Health Study: industry and occupation of glioma cases and controls. , 2012, American journal of industrial medicine.
[37] Andrey Korshunov,et al. Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations , 2012, Acta Neuropathologica.
[38] Melissa Bondy,et al. Genome-wide association study of glioma and meta-analysis , 2012, Human Genetics.
[39] K. P. Kim,et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study , 2012, The Lancet.
[40] A. Ahlbom,et al. Association Between Prediagnostic IgE Levels and Risk of Glioma , 2012, Journal of the National Cancer Institute.
[41] M. Sant,et al. Survival of European patients with central nervous system tumors , 2012, International journal of cancer.
[42] R. McLendon,et al. Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas , 2012, Oncotarget.
[43] Damien C Weber,et al. Epidemiology of glial and non-glial brain tumours in Europe. , 2012, European journal of cancer.
[44] J. Olson,et al. Rare TP53 genetic variant associated with glioma risk and outcome , 2012, Journal of Medical Genetics.
[45] P. Stewart,et al. The upper midwest health study: a case–control study of pesticide applicators and risk of glioma , 2012, Environmental Health.
[46] K. Pooley,et al. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. , 2012, Journal of the National Cancer Institute.
[47] Sohee Park,et al. Population-based survival data for brain tumors in Korea , 2012, Journal of Neuro-Oncology.
[48] Eugenio Picano,et al. Cancer and non-cancer brain and eye effects of chronic low-dose ionizing radiation exposure , 2012, BMC Cancer.
[49] J. King,et al. Adult glioblastoma multiforme survival in the temozolomide era: A population‐based analysis of Surveillance, Epidemiology, and End Results registries , 2012, Cancer.
[50] S. Devesa,et al. Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States , 2012, BMJ : British Medical Journal.
[51] Donald L. Miller,et al. Cancer risks associated with external radiation from diagnostic imaging procedures , 2012, CA: a cancer journal for clinicians.
[52] Anssi Auvinen,et al. Mobile Phone Use and Incidence of Glioma in the Nordic Countries 1979–2008: Consistency Check , 2012, Epidemiology.
[53] M. Turner. Epidemiology: allergy history, IgE, and cancer , 2012, Cancer Immunology, Immunotherapy.
[54] R. Weichselbaum,et al. Improved survival time trends for glioblastoma using the SEER 17 population-based registries , 2012, Journal of Neuro-Oncology.
[55] M. Boakye,et al. Patterns of care and survival for glioblastoma patients in the Veterans population , 2012, Journal of Neuro-Oncology.
[56] Caleb F. Davis,et al. Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. , 2011, Cancer research.
[57] B. Shadbolt,et al. Increasing incidence of glioblastoma multiforme and meningioma, and decreasing incidence of Schwannoma (2000–2008): Findings of a multicenter Australian study , 2011, Surgical neurology international.
[58] W. Willett,et al. Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. , 2011, Journal of the National Cancer Institute.
[59] M. Wrensch,et al. Effects of antihistamine and anti‐inflammatory medication use on risk of specific glioma histologies , 2011, International journal of cancer.
[60] Kari Stefansson,et al. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility , 2011, Nature Genetics.
[61] E. Riboli,et al. Primary brain tumours and specific serum immunoglobulin E: a case–control study nested in the European Prospective Investigation into Cancer and Nutrition cohort , 2011, Allergy.
[62] J. Olsen,et al. Use of mobile phones and risk of brain tumours: update of Danish cohort study , 2011, BMJ : British Medical Journal.
[63] Stéphane Ducamp,et al. Occupational and residential exposure to electromagnetic fields and risk of brain tumors in adults: A case–control study in Gironde, France , 2011, International journal of cancer.
[64] Pieter Wesseling,et al. A Hypermethylated Phenotype Is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951 , 2011, Clinical Cancer Research.
[65] Yuchen Jiao,et al. Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma , 2011, Science.
[66] Faith Davis,et al. Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking. , 2011, American journal of epidemiology.
[67] R. Dubrow,et al. Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007 , 2011, BMC Cancer.
[68] Melissa Bondy,et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. , 2011, Human molecular genetics.
[69] K. Straif,et al. Carcinogenicity of radiofrequency electromagnetic fields. , 2011, The Lancet. Oncology.
[70] Ying Mao,et al. Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population. , 2011, American journal of epidemiology.
[71] D. Bigner,et al. Medical Diagnostic Radiation Exposures and Risk of Gliomas , 2011, Radiation research.
[72] D. Bigner,et al. Assessment of Type of Allergy and Antihistamine Use in the Development of Glioma , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[73] K. Aldape,et al. Risk factors for oligodendroglial tumors: a pooled international study. , 2011, Neuro-oncology.
[74] B. O'neill,et al. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. , 2011, Cancer genetics.
[75] Hongyan Chen,et al. Single nucleotide polymorphisms in IL-4Ra, IL-13 and STAT6 genes occurs in brain glioma. , 2011, Frontiers in bioscience.
[76] M. Little,et al. Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[77] G. Reifenberger,et al. Patients with IDH 1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH 1-mutated glioblastomas , and IDH 1 mutation status accounts for the unfavorable prognostic effect of higher age : implications for classification of gliomas , 2010 .
[78] Chang-Hyun Lee,et al. Epidemiology of primary brain and central nervous system tumors in Korea. , 2010, Journal of Korean Neurosurgical Society.
[79] Susan M. Chang,et al. Inherited variation in immune genes and pathways and glioblastoma risk , 2010, Carcinogenesis.
[80] H. Duffau,et al. Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. , 2010, Neuro-oncology.
[81] Nader Sanai,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma. , 2010, World neurosurgery.
[82] K. Hoang-Xuan,et al. All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2 , 2010, Neurology.
[83] A. Auvinen,et al. Interaction between 5 genetic variants and allergy in glioma risk. , 2010, American journal of epidemiology.
[84] M. Geraci,et al. Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979-2003. , 2010, European journal of cancer.
[85] R. Wilson,et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.
[86] M. Gilbert,et al. Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. , 2010, Neuro-oncology.
[87] E. Chiocca,et al. Allergy and inflammatory transcriptome is predominantly negatively correlated with CD133 expression in glioblastoma. , 2010, Neuro-oncology.
[88] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[89] A. Zuckerman,et al. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.
[90] G. Reifenberger,et al. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[91] Melissa Bondy,et al. Genome-wide association study identifies five susceptibility loci for glioma , 2009, Nature Genetics.
[92] J. Birch,et al. Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England. , 2009, Neuro-oncology.
[93] Susan M. Chang,et al. IgE, allergy, and risk of glioma: Update from the San Francisco Bay Area Adult Glioma Study in the Temozolomide era , 2009, International journal of cancer.
[94] Alexander R. Pico,et al. Variants in the CDKN2B and RTEL1 regions are associated with high grade glioma susceptibility , 2009, Nature Genetics.
[95] H. Heinzl,et al. The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry , 2009, Journal of Neuro-Oncology.
[96] P. Black,et al. Occupational exposure to magnetic fields and the risk of brain tumors. , 2009, Neuro-oncology.
[97] C. Johansen,et al. Incidence of and survival from oligodendroglioma in Denmark, 1943-2002. , 2009, Neuro-oncology.
[98] M. Blettner,et al. History of allergic disease and epilepsy and risk of glioma and meningioma (INTERPHONE study group, Germany) , 2009, European Journal of Epidemiology.
[99] A. Kyritsis,et al. Descriptive Epidemiology of Cerebral Gliomas in Northwest Greece and Study of Potential Predisposing Factors, 2005–2007 , 2009, Neuroepidemiology.
[100] D. Bigner,et al. Association between Glioma and History of Allergies, Asthma, and Eczema: A Case-Control Study with Three Groups of Controls , 2009, Cancer Epidemiology Biomarkers & Prevention.
[101] Pär Sparén,et al. Occupation and cancer – follow-up of 15 million people in five Nordic countries , 2009, Acta oncologica.
[102] J. Menten,et al. MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma. , 2009, European journal of cancer.
[103] F. Ducray,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[104] Tarik Tihan,et al. Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium , 2008, Cancer.
[105] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[106] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[107] Leeka Kheifets,et al. Occupational Electromagnetic Fields and Leukemia and Brain Cancer: An Update to Two Meta-Analyses , 2008, Journal of occupational and environmental medicine.
[108] A. Lophatananon,et al. Functional Polymorphisms in Folate Metabolism Genes Influence the Risk of Meningioma and Glioma , 2008, Cancer Epidemiology Biomarkers & Prevention.
[109] K. Aldape,et al. Long-term Anti-inflammatory and Antihistamine Medication Use and Adult Glioma Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.
[110] Patricia A Stewart,et al. Occupational exposure to pesticides and risk of adult brain tumors. , 2008, American journal of epidemiology.
[111] B. Devilliers. Environmental Health Criteria 238: EXTREMELY LOW FREQUENCY FIELDS , 2008 .
[112] N. Rothman,et al. Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. , 2007, Carcinogenesis.
[113] E. Linos,et al. Atopy and risk of brain tumors: a meta-analysis. , 2007, Journal of the National Cancer Institute.
[114] P. Hall,et al. Allergic conditions and brain tumor risk. , 2007, American journal of epidemiology.
[115] G. Giles,et al. Occupational exposure to ionizing and non-ionizing radiation and risk of glioma. , 2007, Occupational medicine.
[116] A. Olshan,et al. DNA Repair Polymorphisms XRCC1 and MGMT and Risk of Adult Gliomas , 2007, Neuroepidemiology.
[117] Mark R Gilbert,et al. Chemoradiotherapy in malignant glioma: standard of care and future directions. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[118] Hongliang Liu,et al. Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. , 2007, Carcinogenesis.
[119] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[120] Anssi Auvinen,et al. Incidence of gliomas by anatomic location. , 2007, Neuro-oncology.
[121] D. L. Preston,et al. Solid Cancer Incidence in Atomic Bomb Survivors: 1958–1998 , 2007, Radiation research.
[122] M. Moghadassi,et al. Allergy-Related Polymorphisms Influence Glioma Status and Serum IgE Levels , 2007, Cancer Epidemiology Biomarkers & Prevention.
[123] P. Brochard,et al. Brain tumours and exposure to pesticides: a case–control study in southwestern France , 2007, Occupational and Environmental Medicine.
[124] M. Egger,et al. Leukaemia, brain tumours and exposure to extremely low frequency magnetic fields: cohort study of Swiss railway employees , 2007, Occupational and Environmental Medicine.
[125] C. Johansen,et al. Risk for leukaemia and brain and breast cancer among Danish utility workers: a second follow-up , 2007, Occupational and Environmental Medicine.
[126] P. Kleihues,et al. Genetic pathways to primary and secondary glioblastoma. , 2007, The American journal of pathology.
[127] G. Giles,et al. Occupational exposure to low frequency magnetic fields and the risk of low grade and high grade glioma , 2007, Cancer Causes & Control.
[128] A. Swerdlow,et al. History of allergies and risk of glioma in adults , 2006, International journal of cancer.
[129] Yan Liu,et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. , 2006, Journal of the National Cancer Institute.
[130] J. Tseng,et al. Comparison of effects of socioeconomic and geographic variations on survival for adults and children with glioma. , 2006, Journal of neurosurgery.
[131] S. Pan,et al. Occupational Risk Factors for Brain Cancer in Canada , 2005, Journal of occupational and environmental medicine.
[132] B. Modan,et al. Long-Term Follow-up for Brain Tumor Development after Childhood Exposure to Ionizing Radiation for Tinea Capitis , 2005, Radiation research.
[133] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[134] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[135] W. Sanderson,et al. Gliomas and Farm Pesticide Exposure in Women: The Upper Midwest Health Study , 2005, Environmental health perspectives.
[136] W. Sanderson,et al. Gliomas and Farm Pesticide Exposure in Men: The Upper Midwest Health Study , 2004, Archives of environmental health.
[137] O. Nanni,et al. Cancer Mortality in a Cohort of Male Agricultural Workers From Northern Italy , 2004, Journal of occupational and environmental medicine.
[138] P. Black,et al. Occupation and the risk of adult glioma in the United States , 2003, Cancer Causes & Control.
[139] Bengt Knave,et al. Occupational exposure to electromagnetic fields in relation to leukemia and brain tumors: a case-control study in Sweden , 1993, Cancer Causes & Control.
[140] Per Gustavsson,et al. Interactive effect of chemical substances and occupational electromagnetic field exposure on the risk of gliomas and meningiomas in Swedish men. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[141] G. Eichholz. Non-ionizing Radiation, Part 1: Static and Extremely Low-frequency (elf) Electric and Magnetic Fields, , 2002 .
[142] C. Johansen,et al. Cancer incidence and magnetic field exposure in industries using resistance welding in Sweden , 2002, Occupational and environmental medicine.
[143] 森本 泰夫. IARC Working Group on the Evaluation of Carcinogenic Risks of Man-made Vitreous Fibers to Humans , 2002 .
[144] G. Giles,et al. Contacts with animals and humans as risk factors for adult brain tumours. An international case-control study. , 2002, European journal of cancer.
[145] P. Villeneuve,et al. Brain cancer and occupational exposure to magnetic fields among men: results from a Canadian population-based case-control study. , 2002, International journal of epidemiology.
[146] R. Selway,et al. Posterior lumbar interbody fusion for revision disc surgery: review of 50 cases in which carbon fiber cages were implanted. , 2001, Journal of neurosurgery.
[147] T Sorahan,et al. Occupational exposure to magnetic fields relative to mortality from brain tumours: updated and revised findings from a study of United Kingdom electricity generation and transmission workers, 1973–97 , 2001, Occupational and environmental medicine.
[148] Z L Gokaslan,et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.
[149] C. Lynch,et al. Occupational Risk Factors for Brain Cancer: A Population-Based Case-Control Study in Iowa , 2001, Journal of occupational and environmental medicine.
[150] C. Amos,et al. Segregation analysis of cancer in families of glioma patients , 2001, Genetic epidemiology.
[151] L. Kheifets,et al. Electric and magnetic field exposure and brain cancer: a review. , 2001, Bioelectromagnetics.
[152] F. Davis,et al. Epidemiology of brain tumors. , 2000, Current opinion in neurology.
[153] Scar,et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. , 2000, The New England journal of medicine.
[154] H. Zhou,et al. Case-cohort analysis of brain cancer and leukemia in electric utility workers using a refined magnetic field job-exposure matrix. , 2000, American journal of industrial medicine.
[155] B. Scheithauer,et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[156] S. Khuder,et al. Meta-analyses of brain cancer and farming. , 1998, American journal of industrial medicine.
[157] J. Viel,et al. Brain cancer mortality among French farmers: the vineyard pesticide hypothesis. , 1998, Archives of environmental health.
[158] M Feychting,et al. Occupational and Residential Magnetic Field Exposure and Leukemia and Central Nervous System Tumors , 1997, Epidemiology.
[159] G Thériault,et al. Cancer risks associated with occupational exposure to magnetic fields among electric utility workers in Ontario and Quebec, Canada, and France: 1970-1989. , 1994, American journal of epidemiology.
[160] T. Dragani. Libri Ricevuti: Iarc Monographs on the Evaluation of Carcinogenic Risks to Humans , 1992 .
[161] T. Tynes,et al. Incidence of cancer in Norwegian workers potentially exposed to electromagnetic fields. , 1992, American journal of epidemiology.
[162] Siv G. Tornqvist,et al. Incidence of leukaemia and brain tumours in some "electrical occupations". , 1991, British journal of industrial medicine.
[163] B. Henderson,et al. Risk factors for gliomas and meningiomas in males in Los Angeles County. , 1989, Cancer research.
[164] J. Fraumeni,et al. Occupational risks for intracranial gliomas in Sweden. , 1987, Journal of the National Cancer Institute.
[165] R. Barnard,et al. The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.
[166] Illinois.,et al. Cancer Genetics , 1976, British Journal of Cancer.